Tumorigenicity of embryonic/germ cells |
Preimplantation embryo, EC cells, ES cells, early PGCs, EGCs, iPS cells, Parthenogenetic oocytes |
19, 24–58, 85, 86
|
Extensive expression of embryonic antigens, CT antigens and germ cell antigens in tumors |
About 40 CT antigens, Embryonic/germ cell proteins: Oct4, Sox2, Nanog, SCYP1, SCYP3, DMC1, SSEA1, IFITM3, Stellar, CD117 |
10, 11, 67–74
|
Isolation of cancer stem cells with embryonic/germ cell markers |
SSEA1, CD117 |
72, 74
|
Crucial role of embryonic/germ cell- related genes in tumor malignant traits |
Oct4, Sox2, Nanog, DDX4, PRDM14, IFITM3, DAZL |
70–75, 78–84, 100
|
Role of tumor suppressors/oncogenes in reprogramming and germ cell development. |
P53, Rb, PTEN, C-MYc |
1, 66, 85–90, 158–170
|
Existence of germ cell-like tumor cells in somatic tumor cells |
From PGC-like cells to oocyte-like cells. |
94–100
|
Existence of blastomere-like tumor cells in somatic tumor cells |
preimplantation embryo-like cells at the different developmental stage |
95–100, 119
|